YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression

Nat Commun. 2014 Aug 13:5:4629. doi: 10.1038/ncomms5629.

Abstract

Whether the Hippo pathway contributes to cell lineage transition under pathological conditions, especially tumorigenesis, remains largely unknown. Here we show that YAP, the major effector of the Hippo pathway, displays a distinct activation pattern in lung adenocarcinoma (ADC) and squamous cell carcinoma (SCC); YAP is initially activated by LKB1 loss in lung ADC, which upregulates ZEB2 expression and represses DNp63 transcription in a default manner. During transdifferentiation, YAP is inactivated, which in turn relieves ZEB2-mediated default repression of DNp63 and triggers squamous differentiation reprogramming. Disruption of the YAP barrier for phenotypic transition significantly accelerates squamous transdifferentiation, whereas constitutive YAP activation conversely inhibits this transition. More importantly, ectopic DNp63 expression rescues the inhibitory effect of YAP on squamous transdifferentiation. These findings have established YAP as an essential barrier for lung cancer cell fate conversion and provided a mechanism for regulating cancer plasticity, which might hold important implication for YAP-targeted therapies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • AMP-Activated Protein Kinases
  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / physiology*
  • Adenocarcinoma / genetics*
  • Adenocarcinoma / pathology
  • Adenocarcinoma / physiopathology
  • Animals
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / physiopathology
  • Cell Cycle Proteins
  • Cell Line, Tumor
  • Cell Transdifferentiation / genetics
  • Cell Transdifferentiation / physiology*
  • Disease Models, Animal
  • Down-Regulation / physiology
  • Female
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / physiology
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / physiopathology
  • Male
  • Mice
  • Mice, Transgenic
  • Middle Aged
  • Phosphoproteins / genetics
  • Phosphoproteins / physiology*
  • Protein Serine-Threonine Kinases / deficiency
  • Protein Serine-Threonine Kinases / genetics
  • Repressor Proteins / genetics
  • Repressor Proteins / physiology
  • Trans-Activators / genetics
  • Trans-Activators / physiology
  • Transcription Factors / genetics
  • Transcription Factors / physiology
  • Tumor Suppressor Proteins / genetics
  • Tumor Suppressor Proteins / physiology
  • Up-Regulation / physiology
  • YAP-Signaling Proteins
  • Zinc Finger E-box Binding Homeobox 2

Substances

  • Adaptor Proteins, Signal Transducing
  • Cell Cycle Proteins
  • Homeodomain Proteins
  • Phosphoproteins
  • Repressor Proteins
  • TP63 protein, human
  • Trans-Activators
  • Transcription Factors
  • Trp63 protein, mouse
  • Tumor Suppressor Proteins
  • YAP-Signaling Proteins
  • YAP1 protein, human
  • Yap1 protein, mouse
  • ZEB2 protein, human
  • ZEB2 protein, mouse
  • Zinc Finger E-box Binding Homeobox 2
  • Protein Serine-Threonine Kinases
  • STK11 protein, human
  • Stk11 protein, mouse
  • AMP-Activated Protein Kinase Kinases
  • AMP-Activated Protein Kinases